跳至主要内容
临床试验/JPRN-jRCTs011180001
JPRN-jRCTs011180001已完成2 期

Cerebral Blood Flow Measurement using PSO17 in Patients with Epilepsy - PSO17-04

Kudo Kohsuke0 个研究点目标入组 10 人开始时间: 2018年11月12日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 16age old 至 <= 64age old(—)
性别
All

入选标准

  • (1) Patients with symptomatic localized epilepsy who admitted Hokkaido University Hospital (pediatric ward or epilepsy center)
  • (2) From 16 to 64 years old when informed consent is obtained
  • (3) Body weight equal or less than 80 Kg
  • (4) At least one episode of epileptic seizure during one year before informed consent
  • (5) Focal cortical dysplasia, hippocampal sclerosis, cavernous angioma, DNT, or ganglioglioma was diagnosed on MRI
  • (6) epileptic focus is identified on electrophysiological studies (electroencephalography or magnetoencephalography) or functional brain imaging (FDG-PET or SPECT), and interictal FDG-PET was carried out within one year before informed consent or is scheduled within 6 months after obtaining informed consent.
  • (7) Written informed consent is obtained after sufficient explanation and full understanding

排除标准

  • (1) Contraindication for MRI such as metallic implant (excluding MRI conditional devises), tattoo in the upper body, or claustrophobia
  • (2) Severe cardiovascular or renal dysfunction
  • (3) Unable to securing venous access
  • (4) Pregnant, suspected pregnancy, plan for pregnancy, refusing contraception including partner, or breast feeding
  • (5) Other reason for inadequacy to admit this study judged by principal investigator or co-investigators

研究者

发起方
Kudo Kohsuke

相似试验